Patricia Cowan
Concepts (236)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Overweight | 6 | 2024 | 239 | 1.080 |
Why?
| Learning | 2 | 2022 | 175 | 1.010 |
Why?
| Students, Nursing | 2 | 2022 | 60 | 0.930 |
Why?
| Obesity | 16 | 2024 | 1197 | 0.930 |
Why?
| Adiposity | 2 | 2024 | 142 | 0.890 |
Why?
| Faculty, Nursing | 2 | 2022 | 27 | 0.870 |
Why?
| Kidney Transplantation | 10 | 2015 | 188 | 0.690 |
Why?
| Education, Nursing, Graduate | 2 | 2016 | 25 | 0.670 |
Why?
| Prediabetic State | 2 | 2016 | 22 | 0.660 |
Why?
| Physicians | 1 | 2022 | 247 | 0.660 |
Why?
| Men | 1 | 2015 | 10 | 0.540 |
Why?
| Fellowships and Scholarships | 1 | 2015 | 117 | 0.490 |
Why?
| Diabetes Mellitus, Type 2 | 4 | 2016 | 481 | 0.490 |
Why?
| Weight Gain | 5 | 2015 | 243 | 0.420 |
Why?
| Body Mass Index | 10 | 2024 | 712 | 0.390 |
Why?
| Body Composition | 6 | 2024 | 349 | 0.380 |
Why?
| Nursing Education Research | 3 | 2022 | 42 | 0.380 |
Why?
| Heart Rate | 7 | 2013 | 357 | 0.350 |
Why?
| Kidney Failure, Chronic | 5 | 2017 | 231 | 0.330 |
Why?
| Education, Professional | 1 | 2008 | 6 | 0.320 |
Why?
| Humans | 45 | 2024 | 54246 | 0.320 |
Why?
| Leadership | 2 | 2022 | 114 | 0.320 |
Why?
| Health Occupations | 1 | 2008 | 12 | 0.320 |
Why?
| Dyslipidemias | 1 | 2007 | 40 | 0.300 |
Why?
| Exercise | 7 | 2013 | 548 | 0.280 |
Why?
| Cardiovascular Diseases | 2 | 2011 | 475 | 0.270 |
Why?
| Blood Glucose | 4 | 2016 | 488 | 0.270 |
Why?
| Internet | 1 | 2008 | 275 | 0.270 |
Why?
| Male | 29 | 2024 | 27312 | 0.260 |
Why?
| Adolescent | 11 | 2024 | 6885 | 0.260 |
Why?
| Insulin Resistance | 3 | 2016 | 300 | 0.250 |
Why?
| Caregivers | 2 | 2017 | 240 | 0.250 |
Why?
| Meta-Analysis as Topic | 1 | 2004 | 39 | 0.250 |
Why?
| Sirolimus | 2 | 2003 | 65 | 0.240 |
Why?
| Absorptiometry, Photon | 1 | 2024 | 174 | 0.230 |
Why?
| Insulin | 5 | 2008 | 510 | 0.230 |
Why?
| Immunosuppressive Agents | 3 | 2003 | 248 | 0.230 |
Why?
| Adipose Tissue | 2 | 2024 | 207 | 0.230 |
Why?
| Female | 29 | 2024 | 28418 | 0.220 |
Why?
| Evidence-Based Medicine | 1 | 2004 | 281 | 0.220 |
Why?
| Hypertrophy, Left Ventricular | 2 | 2013 | 40 | 0.210 |
Why?
| Teaching | 1 | 2022 | 127 | 0.190 |
Why?
| Nurses | 1 | 2020 | 52 | 0.190 |
Why?
| Graft Rejection | 1 | 2000 | 161 | 0.180 |
Why?
| Risk Factors | 12 | 2015 | 3930 | 0.180 |
Why?
| Hospitals | 1 | 2020 | 188 | 0.170 |
Why?
| Cohort Studies | 4 | 2016 | 1543 | 0.170 |
Why?
| Child | 10 | 2016 | 7337 | 0.160 |
Why?
| Age Factors | 3 | 2016 | 1195 | 0.150 |
Why?
| Islets of Langerhans | 2 | 2008 | 23 | 0.150 |
Why?
| Electrocardiography, Ambulatory | 4 | 2013 | 25 | 0.150 |
Why?
| Pancreas Transplantation | 3 | 2003 | 20 | 0.150 |
Why?
| Nurses, Male | 1 | 2016 | 1 | 0.150 |
Why?
| Schools, Nursing | 1 | 2016 | 4 | 0.150 |
Why?
| Regression Analysis | 2 | 2016 | 445 | 0.150 |
Why?
| Tissue Donors | 2 | 2008 | 110 | 0.140 |
Why?
| Vulnerable Populations | 1 | 2016 | 44 | 0.140 |
Why?
| Sex Factors | 2 | 2016 | 765 | 0.140 |
Why?
| Education, Nursing | 1 | 2016 | 28 | 0.140 |
Why?
| Multivariate Analysis | 2 | 2016 | 643 | 0.140 |
Why?
| Carboxypeptidase H | 1 | 2015 | 1 | 0.140 |
Why?
| Receptors, Dopamine D4 | 1 | 2015 | 9 | 0.140 |
Why?
| Hypoglycemic Agents | 2 | 2007 | 177 | 0.140 |
Why?
| Dopamine Plasma Membrane Transport Proteins | 1 | 2015 | 46 | 0.130 |
Why?
| Adaptation, Psychological | 1 | 2017 | 244 | 0.130 |
Why?
| Achievement | 1 | 2015 | 46 | 0.130 |
Why?
| Minority Groups | 1 | 2016 | 135 | 0.130 |
Why?
| Career Choice | 1 | 2016 | 116 | 0.130 |
Why?
| Qualitative Research | 3 | 2020 | 331 | 0.130 |
Why?
| Receptors, Dopamine D2 | 1 | 2015 | 17 | 0.130 |
Why?
| Prevalence | 5 | 2011 | 1022 | 0.130 |
Why?
| Physical Endurance | 2 | 2005 | 49 | 0.130 |
Why?
| Adult | 20 | 2016 | 14182 | 0.120 |
Why?
| Glucagon | 2 | 2004 | 34 | 0.120 |
Why?
| Protein Precursors | 2 | 2004 | 47 | 0.120 |
Why?
| Octreotide | 2 | 2004 | 13 | 0.120 |
Why?
| Depressive Disorder | 1 | 2016 | 368 | 0.120 |
Why?
| Educational Measurement | 1 | 2015 | 232 | 0.120 |
Why?
| Electrocardiography | 2 | 2013 | 290 | 0.120 |
Why?
| Child Welfare | 1 | 2013 | 73 | 0.120 |
Why?
| Physical Fitness | 1 | 2013 | 69 | 0.120 |
Why?
| United States | 5 | 2020 | 5200 | 0.110 |
Why?
| Blood Pressure | 3 | 2011 | 586 | 0.110 |
Why?
| Clinical Competence | 1 | 2016 | 446 | 0.110 |
Why?
| Self Efficacy | 1 | 2013 | 137 | 0.110 |
Why?
| Glucagon-Like Peptide 1 | 3 | 2008 | 31 | 0.110 |
Why?
| Peptide Fragments | 2 | 2004 | 242 | 0.110 |
Why?
| Motor Activity | 1 | 2013 | 247 | 0.100 |
Why?
| Depression | 1 | 2017 | 594 | 0.100 |
Why?
| Sex Offenses | 1 | 2013 | 82 | 0.100 |
Why?
| Long QT Syndrome | 1 | 2011 | 12 | 0.100 |
Why?
| Risk Assessment | 1 | 2016 | 1361 | 0.100 |
Why?
| Retrospective Studies | 6 | 2016 | 6432 | 0.100 |
Why?
| Calcium, Dietary | 1 | 2010 | 15 | 0.100 |
Why?
| Heart Conduction System | 1 | 2010 | 25 | 0.100 |
Why?
| Health Promotion | 1 | 2013 | 300 | 0.100 |
Why?
| Cell Separation | 2 | 2008 | 107 | 0.090 |
Why?
| Diet | 2 | 2012 | 597 | 0.090 |
Why?
| Child, Preschool | 2 | 2016 | 4146 | 0.090 |
Why?
| Glucose Intolerance | 1 | 2009 | 28 | 0.090 |
Why?
| Pilot Projects | 4 | 2015 | 808 | 0.090 |
Why?
| Insulin-Secreting Cells | 1 | 2008 | 23 | 0.080 |
Why?
| Death, Sudden, Cardiac | 2 | 2000 | 60 | 0.080 |
Why?
| Kidney Diseases | 1 | 2012 | 293 | 0.080 |
Why?
| Education, Continuing | 1 | 2008 | 22 | 0.080 |
Why?
| Middle Aged | 12 | 2015 | 13070 | 0.080 |
Why?
| Liver Transplantation | 2 | 2001 | 160 | 0.080 |
Why?
| Stress Disorders, Post-Traumatic | 1 | 2013 | 394 | 0.080 |
Why?
| Energy Intake | 4 | 2015 | 196 | 0.080 |
Why?
| Heart Diseases | 1 | 2011 | 237 | 0.080 |
Why?
| Anti-Obesity Agents | 1 | 2007 | 22 | 0.080 |
Why?
| Hypolipidemic Agents | 1 | 2007 | 33 | 0.080 |
Why?
| Quality of Life | 3 | 2014 | 922 | 0.080 |
Why?
| Islets of Langerhans Transplantation | 1 | 2006 | 2 | 0.070 |
Why?
| Dietary Carbohydrates | 2 | 2004 | 89 | 0.070 |
Why?
| Tissue and Organ Harvesting | 1 | 2006 | 27 | 0.070 |
Why?
| Analysis of Variance | 4 | 2013 | 635 | 0.070 |
Why?
| Young Adult | 5 | 2016 | 4308 | 0.070 |
Why?
| Veterans | 1 | 2013 | 629 | 0.070 |
Why?
| Antihypertensive Agents | 1 | 2007 | 139 | 0.070 |
Why?
| Metformin | 1 | 2007 | 66 | 0.070 |
Why?
| Life Style | 1 | 2007 | 156 | 0.070 |
Why?
| Attitude to Health | 1 | 2007 | 226 | 0.070 |
Why?
| Tennessee | 3 | 2016 | 43 | 0.070 |
Why?
| Motivation | 1 | 2007 | 291 | 0.070 |
Why?
| Pyruvic Acid | 1 | 2005 | 24 | 0.070 |
Why?
| Primary Health Care | 1 | 2009 | 400 | 0.060 |
Why?
| Glucose Tolerance Test | 4 | 2008 | 67 | 0.060 |
Why?
| Aged | 7 | 2015 | 10041 | 0.060 |
Why?
| Glycemic Index | 1 | 2004 | 5 | 0.060 |
Why?
| Task Performance and Analysis | 1 | 2004 | 61 | 0.060 |
Why?
| Bicycling | 1 | 2004 | 43 | 0.060 |
Why?
| Statistics as Topic | 1 | 2004 | 103 | 0.060 |
Why?
| Exercise Test | 2 | 2005 | 151 | 0.060 |
Why?
| Anthropometry | 3 | 2013 | 96 | 0.060 |
Why?
| Mycophenolic Acid | 1 | 2003 | 17 | 0.060 |
Why?
| Inflammation | 1 | 2008 | 674 | 0.060 |
Why?
| Calcium | 1 | 2005 | 432 | 0.050 |
Why?
| Eating | 1 | 2003 | 155 | 0.050 |
Why?
| Patient Selection | 2 | 2000 | 286 | 0.050 |
Why?
| Renal Dialysis | 2 | 2000 | 192 | 0.050 |
Why?
| Dietary Supplements | 1 | 2005 | 449 | 0.050 |
Why?
| Transplantation Immunology | 1 | 2000 | 6 | 0.050 |
Why?
| Workflow | 1 | 2020 | 57 | 0.050 |
Why?
| Intestinal Absorption | 1 | 2000 | 60 | 0.050 |
Why?
| Drug Costs | 1 | 2000 | 35 | 0.050 |
Why?
| Autonomic Nervous System Diseases | 1 | 2000 | 13 | 0.050 |
Why?
| Weight Loss | 1 | 2003 | 271 | 0.050 |
Why?
| Nurse's Role | 1 | 2000 | 90 | 0.050 |
Why?
| Safety | 1 | 2000 | 92 | 0.050 |
Why?
| Drug Interactions | 1 | 2000 | 206 | 0.050 |
Why?
| Prospective Studies | 5 | 2009 | 2604 | 0.050 |
Why?
| Patient Safety | 1 | 2020 | 121 | 0.050 |
Why?
| Arrhythmias, Cardiac | 1 | 2000 | 98 | 0.050 |
Why?
| Renal Insufficiency | 1 | 2001 | 138 | 0.040 |
Why?
| Reference Values | 2 | 2013 | 354 | 0.040 |
Why?
| Feeding Behavior | 2 | 2014 | 199 | 0.040 |
Why?
| Case-Control Studies | 3 | 2013 | 1228 | 0.040 |
Why?
| Clinical Trials as Topic | 1 | 2000 | 490 | 0.040 |
Why?
| Thermolysin | 2 | 2008 | 3 | 0.040 |
Why?
| Collagenases | 2 | 2008 | 28 | 0.040 |
Why?
| Postoperative Complications | 2 | 2003 | 1033 | 0.040 |
Why?
| Cost of Illness | 1 | 2017 | 132 | 0.040 |
Why?
| School Admission Criteria | 1 | 2016 | 37 | 0.040 |
Why?
| Linear Models | 2 | 2007 | 309 | 0.040 |
Why?
| Minisatellite Repeats | 1 | 2015 | 6 | 0.030 |
Why?
| Time Factors | 4 | 2005 | 3212 | 0.030 |
Why?
| Educational Status | 1 | 2016 | 259 | 0.030 |
Why?
| Program Development | 1 | 2016 | 199 | 0.030 |
Why?
| Optogenetics | 1 | 2015 | 8 | 0.030 |
Why?
| Logistic Models | 2 | 2009 | 990 | 0.030 |
Why?
| Cell Survival | 2 | 2008 | 657 | 0.030 |
Why?
| Sensitivity and Specificity | 2 | 2013 | 923 | 0.030 |
Why?
| Genetic Association Studies | 1 | 2015 | 136 | 0.030 |
Why?
| Neuroimaging | 1 | 2015 | 88 | 0.030 |
Why?
| Treatment Outcome | 2 | 2007 | 5604 | 0.030 |
Why?
| Social Support | 1 | 2016 | 298 | 0.030 |
Why?
| Reward | 1 | 2015 | 123 | 0.030 |
Why?
| Physical Education and Training | 1 | 2013 | 27 | 0.030 |
Why?
| Curriculum | 1 | 2016 | 429 | 0.030 |
Why?
| School Health Services | 1 | 2013 | 52 | 0.030 |
Why?
| Double-Blind Method | 2 | 2005 | 742 | 0.030 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2015 | 552 | 0.030 |
Why?
| Body Weight | 1 | 2015 | 578 | 0.030 |
Why?
| ROC Curve | 1 | 2013 | 259 | 0.030 |
Why?
| Genetic Predisposition to Disease | 1 | 2015 | 570 | 0.030 |
Why?
| Program Evaluation | 1 | 2013 | 374 | 0.030 |
Why?
| Neurons | 1 | 2015 | 486 | 0.020 |
Why?
| Diet Records | 1 | 2010 | 24 | 0.020 |
Why?
| Minerals | 1 | 2010 | 36 | 0.020 |
Why?
| Vitamins | 1 | 2010 | 72 | 0.020 |
Why?
| Echocardiography | 1 | 2013 | 392 | 0.020 |
Why?
| Physical Examination | 1 | 2009 | 99 | 0.020 |
Why?
| Cholesterol | 1 | 2009 | 155 | 0.020 |
Why?
| Diabetes Complications | 2 | 2000 | 122 | 0.020 |
Why?
| C-Peptide | 1 | 2008 | 24 | 0.020 |
Why?
| Cadaver | 1 | 2008 | 113 | 0.020 |
Why?
| Nursing Evaluation Research | 1 | 2007 | 47 | 0.020 |
Why?
| Diet, Reducing | 1 | 2007 | 40 | 0.020 |
Why?
| C-Reactive Protein | 1 | 2008 | 159 | 0.020 |
Why?
| Comorbidity | 1 | 2009 | 663 | 0.020 |
Why?
| Mice, Inbred NOD | 1 | 2006 | 99 | 0.020 |
Why?
| Mice, SCID | 1 | 2006 | 196 | 0.020 |
Why?
| Follow-Up Studies | 2 | 2003 | 2387 | 0.020 |
Why?
| Mice | 2 | 2008 | 6413 | 0.020 |
Why?
| Health Services Needs and Demand | 1 | 2007 | 189 | 0.020 |
Why?
| Mass Screening | 1 | 2009 | 370 | 0.020 |
Why?
| Behavior Therapy | 1 | 2007 | 203 | 0.020 |
Why?
| Combined Modality Therapy | 1 | 2007 | 692 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2013 | 3429 | 0.020 |
Why?
| Honey | 1 | 2004 | 8 | 0.020 |
Why?
| Gels | 1 | 2004 | 19 | 0.020 |
Why?
| Lipids | 1 | 2005 | 178 | 0.020 |
Why?
| Oxygen Consumption | 1 | 2005 | 223 | 0.010 |
Why?
| Gastrointestinal Agents | 1 | 2004 | 36 | 0.010 |
Why?
| Cross-Over Studies | 1 | 2004 | 250 | 0.010 |
Why?
| Fasting | 1 | 2003 | 76 | 0.010 |
Why?
| Hormones | 1 | 2003 | 59 | 0.010 |
Why?
| Prednisone | 1 | 2003 | 111 | 0.010 |
Why?
| Hypertension | 1 | 2008 | 563 | 0.010 |
Why?
| Cross-Sectional Studies | 1 | 2007 | 1679 | 0.010 |
Why?
| Glucose | 1 | 2004 | 366 | 0.010 |
Why?
| Animals | 2 | 2008 | 14385 | 0.010 |
Why?
| Sickness Impact Profile | 1 | 2000 | 36 | 0.010 |
Why?
| Cyclosporine | 1 | 2001 | 66 | 0.010 |
Why?
| Tacrolimus | 1 | 2001 | 52 | 0.010 |
Why?
| Signal Processing, Computer-Assisted | 1 | 2000 | 92 | 0.010 |
Why?
| Living Donors | 1 | 2000 | 25 | 0.010 |
Why?
| Hospitals, University | 1 | 2000 | 89 | 0.010 |
Why?
| Research | 1 | 2000 | 110 | 0.010 |
Why?
| Graft Survival | 1 | 2000 | 165 | 0.010 |
Why?
| Circadian Rhythm | 1 | 1999 | 85 | 0.010 |
Why?
| Disease Progression | 1 | 2001 | 913 | 0.010 |
Why?
| Risk | 1 | 1998 | 343 | 0.010 |
Why?
| Survival Rate | 1 | 2000 | 951 | 0.010 |
Why?
| Predictive Value of Tests | 1 | 1998 | 1048 | 0.010 |
Why?
|
|
Cowan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
|